Monoclonal antibody therapy in cancer: when two is better (and considerably more expensive) than one

Peterson, Gregory M, Thomas, Jackson, Yee, Kwang C, Kosari, Sam, Naunton, Mark and Olesen, Inger H 2018, Monoclonal antibody therapy in cancer: when two is better (and considerably more expensive) than one, Journal of clinical pharmacy and therapeutics, vol. 43, no. 6, pp. 925-930, doi: 10.1111/jcpt.12750.

Attached Files
Name Description MIMEType Size Downloads

Title Monoclonal antibody therapy in cancer: when two is better (and considerably more expensive) than one
Author(s) Peterson, Gregory M
Thomas, Jackson
Yee, Kwang C
Kosari, Sam
Naunton, Mark
Olesen, Inger H
Journal name Journal of clinical pharmacy and therapeutics
Volume number 43
Issue number 6
Start page 925
End page 930
Total pages 6
Publisher John Wiley & Sons
Place of publication Chichester, Eng.
Publication date 2018-12
ISSN 1365-2710
Keyword(s) cancer
combination
immune checkpoint
monoclonal antibody
toxicity
antibodies, monoclonal
antineoplastic combined chemotherapy protocols
biomarkers, tumor
drug costs
drug resistance, neoplasm
drug synergism
neoplasms
precision medicine
treatment outcome
Language eng
DOI 10.1111/jcpt.12750
Field of Research 1115 Pharmacology And Pharmaceutical Sciences
HERDC Research category C1 Refereed article in a scholarly journal
Copyright notice ©2018, John Wiley & Sons Ltd
Persistent URL http://hdl.handle.net/10536/DRO/DU:30115652

Document type: Journal Article
Collections: Faculty of Health
School of Medicine
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 1 times in TR Web of Science
Scopus Citation Count Cited 1 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 26 Abstract Views, 0 File Downloads  -  Detailed Statistics
Created: Tue, 27 Nov 2018, 09:23:34 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.